Table 3.
Total Cohort (n = 321) | Positive Subjects (n = 31) | Negative Subjects (n = 290) | |
---|---|---|---|
Median age | 37 (13) | 36 (14) | 37 (13) |
Gender | |||
Male | 91 (28%) | 9 (29%) | 82 (28%) |
Female | 230 (72%) | 22 (71%) | 208 (72%) |
Race | |||
Caucasian | 133 (41%) | 13 (42%) | 120 (41%) |
African American | 147 (46%) | 16 (52%) | 131 (45%) |
Hispanic | 13 (4%) | 2 (6%) | 11 (4%) |
Other | 29 (9%) | 0 | 29 (10%) |
Medical Problems | |||
Asthma | 66 (21%) | 7 (23%) | 59 (20%) |
Hypertension | 61 (19%) | 8 (26%) | 53 (18%) |
History of Smoking | 41 (13%) | 3 (10%) | 38 (13%) |
Diabetes | 28 (9%) | 5 (16%) | 23 (8%) |
No Medical History | 176 (55%) | 16 (52%) | 160 (55%) |
Symptoms | |||
Cough | 93 (29%) | 14 (45%) | 79 (27%) |
Headache | 68 (21%) | 11 (35%) | 57 (20%) |
Fever/Chills | 67 (21%) | 11 (35%) | 56 (19%) |
Shortness of Breath | 33 (10%) | 3 (10%) | 30 (10%) |
No Symptoms | 127 (40%) | 6 (19%) | 121 (42%) |